Official UK procurement notice
Cytokine Modulators · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought8 lots · detail below
Published requirement descriptionSupply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications.
Etanercept
Infliximab
Adalimumab
Methotrexate
The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section
II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 5 bids on the busiest of 8 lots · 11 suppliers appointed
Lots and requirements (8)Procurement structure
8 lots · no lot values published · same evaluation weights on every lotLot #1EtanerceptAwarded
Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.
Lot #2Infliximab IVAwarded
Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
Lot #3Infliximab SubcutaneousAwarded
Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.
Lot #4AdalimumabAwarded
Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
Lot #5Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection deviceAwarded
Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.
Lot #6Methotrexate (50 mg per 1 ml concentration ) pre-filled syringesAwarded
Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
Lot #7Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection deviceAwarded
Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
Lot #8Methotrexate (25mg per 1 ml concentration ) pre-filled syringesAwarded
Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Supply Chain: 5%
- price: 95%
Published award criteria (2)
- Supply Chain: 5
- Price: 95
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “Cytokine Modulators” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 11 Feb 2021, 08:56 GMT
- Last source update
- 11 Feb 2021, 08:56 GMT
- Authority reference
NP47920- FTS notice number
2021/S 000-002773- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02923cFind a Tender
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The estimated values referred to in Section II.I.5 and all Lots cover the initial twenty four (24) month duration and the maximum twenty four (24) month extension period. (SC Ref:642734)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast8 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Etanercept
- Signed
- 11 Jan 2021
- Value
- £46,271,726
- Status
- active
Infliximab IV
- Signed
- 11 Jan 2021
- Value
- £18,193,906
- Status
- active
Infliximab Subcutaneous
- Signed
- 11 Jan 2021
- Value
- £307,680
- Status
- active
Adalimumab
- Signed
- 11 Jan 2021
- Value
- £36,167,709
- Status
- active
Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device
- Signed
- 11 Jan 2021
- Value
- £14,775,961
- Status
- active
Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes
- Signed
- 11 Jan 2021
- Value
- £390,136
- Status
- active
Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device
- Signed
- 11 Jan 2021
- Value
- £218,102
- Status
- active
Methotrexate (25mg per 1 ml concentration ) pre-filled syringes
- Signed
- 11 Jan 2021
- Value
- £317,995
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Etanercept | 3bids · 3 electronic · 3 from abroad | 0 | — | — |
| 2 · Infliximab IV | 5bids · 5 electronic · 5 from abroad | 1 | — | — |
| 3 · Infliximab Subcutaneous | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 4 · Adalimumab | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 5 · Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device | 2bids · 2 electronic · 2 from abroad | 1 | — | — |
| 6 · Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 7 · Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 8 · Methotrexate (25mg per 1 ml concentration ) pre-filled syringes | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
12 commercial parties on the notice- AbbVie LtdFramework contractor
- Accord UK LtdFramework contractor
- Accord-UK LtdFramework contractor
- Biogen Idec Ltd.Framework contractor
- Celltrion Healthcare United Kingdom LimitedFramework contractor
- Fresenius Kabi LimitedFramework contractor
- Merck Sharp & DohmeFramework contractor
- Nordic Pharma LtdFramework contractor
- Pfizer LtdFramework contractor
- Sandoz LtdFramework contractor
Show 2 more suppliers
- amgen ltdFramework contractor
- medac Pharma LLPFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.